Related Experiment Videos
[Neonatal heart transplantation. First results]
Summary
Neonatal heart transplantation for hypoplastic left heart syndrome is feasible. Two infants showed good short- and mid-term outcomes, demonstrating hope for complex congenital heart defects.
Area of Science:
- Cardiology
- Pediatric Surgery
- Immunology
Context:
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect requiring intervention.
- Orthotopic heart transplantation is a potential treatment for neonates with inoperable HLHS.
- This study evaluates outcomes in two neonates undergoing heart transplantation for HLHS.
Purpose:
- To assess the feasibility and outcomes of orthotopic heart transplantation in neonates with HLHS.
- To evaluate the short- and mid-term results of neonatal heart transplantation.
- To examine the safety and efficacy of the immunosuppressive protocol used.
Summary:
- Two neonates with HLHS underwent orthotopic heart transplantation with significant donor-recipient weight discrepancies and moderate ischemic times.
- An immunosuppressive protocol involving thymoglobulin induction and a 3-drug regimen with rapid prednisone tapering was employed.
- Both infants experienced one episode of acute rejection, successfully treated, and are currently doing well with normal renal function and growth at 43 and 10 months post-transplant.
Impact:
- Neonatal heart transplantation is a viable option for neonates with inoperable congenital heart defects.
- The study demonstrates good short- and mid-term graft survival and patient well-being.
- Despite ethical considerations, heart transplantation offers significant hope for improving outcomes in this critical patient population.